Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$CHTP trading halted!
$CHTP trading halted!
I wish you luck.
Thanks I appreciate knowing what kind of person I'm dealing with.
If that is yours I'm impressed.
Aw cmon, just for me. Remember I said nothing personal. Credibility lets me know that I can trust what a person says.
Sorry but I just don't believe that. Peeps who can't post a screenshot of that large a position have no credibility. Nothing personal.
$CHTP The last paragraph in that story was left out of your post.
A Northera approval Friday will be more good news for Chelsea, as long as FDA doesn't saddle the drug with significant use restrictions. What Chelsea and its supporters don't want to see is an FDA-approved label which says Northera should not be used longer than 1-2 weeks.
http://bit.ly/1c1jet0
$CHTP Bullshit!
$CHTP How the hell could you possibly know that? Another pumper!
I'll try that. Thanks kk.
Thanks PT.
OT: Can anyone recommend a good brokerage for trading? I have used Schwab for about 15 years but this week they screwed up one of my trades saying I bought a stock at a higher price than what I actually bought it at. They dropped my account balance by $1200.00 but refuse to admit they did, saying their system did not recognize that I bought the stock at an after hours price. I have screenshots of the transaction so eventually I will get my money back. But I have now lost the trust I once had for Schwab.
$CHTP They have to make it public knowledge.
When you own over 5% of outstanding shares it has to be reported.
They own 8.2% of outstanding shares.
Baker Bros., smart investors, good to follow their moves.
Don't know. Do you have a link?
$CHTP 1:56 pm Chelsea says no decision made by FDA on Northera NDA.
http://www.streetinsider.com/Trader+Talk/Chelsea+Therapeutics+%28CHTP%29%3A+No+Decision+Made+by+FDA+on+Northera+NDA+/9175097.html
$CHTP Read it, thanks.
$CHTP You are correct, I just read it. Without links I question things. A lot of bullshit flying around.
Got a link for that?
$CHTP I don't believe CHTP would tell you anything about that.
$CHTP "In my opinion" after reading the adcom notes the word "failed" appeared too many times for my liking. I'm on the sideline, good luck to all still in. I think it will get approved but with label restrictions.
$MSTX When peeps know that the ATM is out of the way it will move again unless major news hits first. IMO
$CHTP HFTs making a lot of money today.
$CHTP It means its very volatile. I sold, staying away from this for now.
$CHTP volatility pause again.
Halt Date Halt Time Issue Symbol Issue Name Market Reason Codes Pause Threshold Price Resumption Date Resumption Quote Time Resumption Trade Time
02/14/2014 11:28:25 CHTP Chelsea Therapeutics NASDAQ
LUDP
02/14/2014 11:28:25
02/14/2014 11:21:21 CHTP Chelsea Therapeutics NASDAQ
LUDP
02/14/2014 11:21:21 11:26:21
02/14/2014 11:15:52 CHTP Chelsea Therapeutics NASDAQ
LUDP
02/14/2014 11:15:52 11:20:52
$CHTP pause ended, now comes the bear raid.
$CHTP
Halt Date Halt Time Issue Symbol Issue Name Market Reason Codes Pause Threshold Price Resumption Date Resumption Quote Time Resumption Trade Time
02/14/2014 11:21:21 CHTP Chelsea Therapeutics NASDAQ
LUDP
02/14/2014 11:21:21
volatility pause
http://bit.ly/MjyYRG
$CHTP trading halted.
$CHTP yeah looks like someone knows and has leaked news.
ok.. 24.48 mil short. that's up from 5,352,469 short as of 1/31/14.
$CHTP Institutional ownership is 40.06% but short interest is 11.90%.
http://yhoo.it/1mg4uQz
$CHTP
Financial Highlights
Short % is 11.90%
Fiscal Year
Fiscal Year Ends: Dec 31
Most Recent Quarter (mrq): Sep 30, 2013
Profitability
Profit Margin (ttm): N/A
Operating Margin (ttm): N/A
Management Effectiveness
Return on Assets (ttm): -29.95%
Return on Equity (ttm): -56.84%
Income Statement
Revenue (ttm): N/A
Revenue Per Share (ttm): N/A
Qtrly Revenue Growth (yoy): N/A
Gross Profit (ttm): N/A
EBITDA (ttm)6: -13.29M
Net Income Avl to Common (ttm): -13.32M
Diluted EPS (ttm): -0.20
Qtrly Earnings Growth (yoy): N/A
Balance Sheet
Total Cash (mrq): 20.88M
Total Cash Per Share (mrq): 0.30
Total Debt (mrq): 0.00
Total Debt/Equity (mrq): N/A
Current Ratio (mrq): 7.48
Book Value Per Share (mrq): 0.28
Cash Flow Statement
Operating Cash Flow (ttm): -15.10M
Levered Free Cash Flow (ttm): -10.14M
View Financials
Income Statement - Balance Sheet - Cash Flow
Trading Information
Stock Price History
Beta: 1.56
52-Week Change3: 525.32%
S&P500 52-Week Change3: 20.40%
52-Week High (Jan 15, 2014)3: 5.78
52-Week Low (Feb 19, 2013)3: 0.76
50-Day Moving Average3: 4.23
200-Day Moving Average3: 3.42
Share Statistics
Avg Vol (3 month)3: 4,099,140
Avg Vol (10 day)3: 5,702,680
Shares Outstanding5: 70.77M
Float: 61.20M
% Held by Insiders1: 8.11%
% Held by Institutions1: 38.00%
Shares Short (as of Jan 15, 2014)3: 7.91M
Short Ratio (as of Jan 15, 2014)3: 1.40
Short % of Float (as of Jan 15, 2014)3: 11.90%
Shares Short (prior month)3: 4.98M
This baby popped because $heff bought in.
Mast Therapeutics, Inc. (MSTX) -NYSE MKT
0.82 Down 0.0049(0.59%) Feb 12, 4:01PM EST|Pre-Market : 0.85 Up 0.03 (3.04%) 8:15AM EST
Add to Portfolio
Analyst Opinion Get Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week): 1.5
Mean Recommendation (last week): 1.5
Change: 0.0
* (Strong Buy) 1.0 - 5.0 (Sell)
Price Target Summary
Mean Target: 2.00
Median Target: 2.00
High Target: 3.00
Low Target: 1.00
No. of Brokers: 2
Data provided by Thomson/First Call
http://yhoo.it/1guhKeK
$DRRX from twitter.
Jason Napodano, CFA ?@JNapodano 1h
I love $DRRX at this level. Remoxy alone is worth more than the current value. PFE stated the BEQ study >> http://clinicaltrials.gov/ct2/show/NCT02059915 …
Jason Napodano, CFA ?@JNapodano 1h
Data from PFE's Abuse potential & BEQ study on Remoxy are due in June 2014. $DRRX people - BTFD.
Jason Napodano, CFA ?@JNapodano 2h
$DRRX CRL not entirely unexpected. Will be interesting to see where the stock opens. I think Remoxy is worth ~$1.50 alone. CC tomorrow 8:30a
I wasn't in this one. Another similar drug on the market already.
$DRRX CRL
CUPERTINO, Calif., Feb. 12, 2014 /PRNewswire/ -- DURECT Corporation (DRRX) today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter for POSIDURâ„¢ (SABER®-Bupivacaine), an investigational drug for administration into the surgical site to produce post-surgical analgesia. Based on its review, the FDA has determined that they cannot approve the NDA in its present form, stating the NDA does not contain sufficient information to demonstrate that POSIDUR is safe when used in the manner described in the proposed label, and the FDA has indicated that additional clinical safety studies need to be conducted. DURECT is evaluating the issues described in the Complete Response Letter and plans to have further discussions with the FDA around them.
(Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO)
"In the coming months, we intend to work with the FDA to gain more clarity on the next steps that would be required to address the issues cited in the Complete Response Letter," stated James E. Brown, DVM, President and CEO of DURECT Corporation.
http://yhoo.it/1eQPx3v